Daniel E Weiner1, Stephen L Seliger. 1. aTufts Medical Center, Boston, Massachusetts bUniversity of Maryland Medical Center, Baltimore VA Medical Center, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Both cognitive and physical function are commonly impaired in individuals with chronic kidney disease (CKD), resulting in important impacts on their quality of life and overall health. This review summarizes the burden of cognitive and physical impairment in CKD, focusing on recent research that highlights a possible unifying microvascular cause among these shared comorbid conditions. RECENT FINDINGS: Multiple small studies have been published recently evaluating cognitive and physical functioning in people with CKD. These studies overall demonstrate a high burden of comorbid conditions in people with CKD, including microvascular disease, that may result in cognitive impairment. Additionally, studies demonstrate that physical function is substantially worse than expected in individuals with CKD, that decreased physical activity is associated with worse outcomes, that frailty is very common and associated with an increased risk of death, and that structured exercise programs have small but tangible short-term effects on markers of physical performance. SUMMARY: Impaired cognitive function and physical performance are important factors impacting the lives of people with CKD. Further research is necessary to better treat these important comorbid conditions in people with CKD.
PURPOSE OF REVIEW: Both cognitive and physical function are commonly impaired in individuals with chronic kidney disease (CKD), resulting in important impacts on their quality of life and overall health. This review summarizes the burden of cognitive and physical impairment in CKD, focusing on recent research that highlights a possible unifying microvascular cause among these shared comorbid conditions. RECENT FINDINGS: Multiple small studies have been published recently evaluating cognitive and physical functioning in people with CKD. These studies overall demonstrate a high burden of comorbid conditions in people with CKD, including microvascular disease, that may result in cognitive impairment. Additionally, studies demonstrate that physical function is substantially worse than expected in individuals with CKD, that decreased physical activity is associated with worse outcomes, that frailty is very common and associated with an increased risk of death, and that structured exercise programs have small but tangible short-term effects on markers of physical performance. SUMMARY:Impaired cognitive function and physical performance are important factors impacting the lives of people with CKD. Further research is necessary to better treat these important comorbid conditions in people with CKD.
Authors: Kristine Yaffe; Lynn Ackerson; Manjula Kurella Tamura; Patti Le Blanc; John W Kusek; Ashwini R Sehgal; Debbie Cohen; Cheryl Anderson; Lawrence Appel; Karen Desalvo; Akinlolu Ojo; Stephen Seliger; Nancy Robinson; Gail Makos; Alan S Go Journal: J Am Geriatr Soc Date: 2010-01-26 Impact factor: 5.562
Authors: Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger Journal: Arch Intern Med Date: 2002-10-14
Authors: Paramjit Kalirao; Sarah Pederson; Robert N Foley; Ali Kolste; David Tupper; David Zaun; Vanessa Buot; Anne M Murray Journal: Am J Kidney Dis Date: 2011-02-04 Impact factor: 8.860
Authors: Lenore J Launer; Timothy Hughes; Binbing Yu; Kamal Masaki; Helen Petrovitch; G Webster Ross; Lon R White Journal: Hypertension Date: 2010-04-19 Impact factor: 10.190
Authors: Manjula Kurella Tamura; Dawei Xie; Kristine Yaffe; Debbie L Cohen; Valerie Teal; Scott E Kasner; Steven R Messé; Ashwini R Sehgal; John Kusek; Karen B DeSalvo; Denise Cornish-Zirker; Janet Cohan; Stephen L Seliger; Glenn M Chertow; Alan S Go Journal: Clin J Am Soc Nephrol Date: 2010-10-07 Impact factor: 8.237
Authors: A M Murray; D E Tupper; D S Knopman; D T Gilbertson; S L Pederson; S Li; G E Smith; A K Hochhalter; A J Collins; R L Kane Journal: Neurology Date: 2006-07-25 Impact factor: 9.910
Authors: Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak Journal: Am J Kidney Dis Date: 2008-12-12 Impact factor: 8.860
Authors: Meera N Harhay; Michael O Harhay; Karthik Ranganna; Suzanne M Boyle; Lissa Levin Mizrahi; Stephen Guy; Gregory E Malat; Gary Xiao; David J Reich; Rachel E Patzer Journal: Clin Transplant Date: 2018-09-15 Impact factor: 2.863
Authors: Tamara Isakova; Joachim H Ix; Stuart M Sprague; Kalani L Raphael; Linda Fried; Jennifer J Gassman; Dominic Raj; Alfred K Cheung; John W Kusek; Michael F Flessner; Myles Wolf; Geoffrey A Block Journal: J Am Soc Nephrol Date: 2015-05-12 Impact factor: 10.121
Authors: Nicholette D Palmer; Kaycee M Sink; Susan Carrie Smith; Jianzhao Xu; Donald W Bowden; Christina E Hugenschmidt; Christopher T Whitlow; Jeff D Williamson; Joseph A Maldjian; Jasmin Divers; Barry I Freedman Journal: Am J Nephrol Date: 2014-10-10 Impact factor: 3.754
Authors: Renata Tiene de Carvalho Yokota; Lenildo de Moura; Silvânia Suely Caribé de Araújo Andrade; Naíza Nayla Bandeira de Sá; Wilma Johanna Nusselder; Herman Van Oyen Journal: Int J Public Health Date: 2016-06-23 Impact factor: 3.380